InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+14.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lund- Jürgensen Kirsten, Executive. Officer active across 1 company, notably UCB. In total, 7 disclosures have been published. History available since 2 October 2025. The latest transaction was disclosed on 10 April 2026 (Sale). Regulator: FSMA. The full history is accessible without signup.
Declarations7 total
3,084 shares@ €270.890.0019% mcap22.3% of flowShareEuronext BrusselsFSMA:ucb-126
3,084 shares0ShareOff exchangeFSMA:ucb-225
Ideal exit: 27 Dec 2026 (T+270)
2,549 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-18
Ideal exit: 27 Dec 2026 (T+270)
3,660 shares@ €287.2928.1% of flowShareEuronext BrusselsFSMA:ucb-125
3,615 shares@ €287.290.0% of flowShareEuronext BrusselsFSMA:ucb-9
3,682 shares@ €287.2928.2% of flowShareEuronext BrusselsFSMA:ucb-181
5,746 shares@ €139.4521.4% of flowOtherOff exchangeFSMA:ucb-31
7 of 7 declarations
About Lund- Jürgensen Kirsten
Kirsten Lund-Jürgensen is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.
